Cargando…
(32) Clozapine Toxicity Following COVID-19 Infection: A Case Series
Autores principales: | DiAngelo, Zachary, Berlin, John Q., Wang, Shiyao, Gutowski, Brianna, Bahnsen, Robert F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646381/ http://dx.doi.org/10.1016/j.jaclp.2022.10.035 |
Ejemplares similares
-
Clozapine Toxicity in the Setting of COVID-19
por: Dotson, Samuel, et al.
Publicado: (2020) -
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report
por: Chengappa, K.N. Roy, et al.
Publicado: (2022) -
A survey of personnel and services offered in 32 outpatient US clozapine clinics
por: Cotes, Robert O., et al.
Publicado: (2021) -
Clozapine/tozinameran: Various toxicities following drug interaction: case report
Publicado: (2022) -
Toxic clozapine level as first indication of severe, acute infection
por: Davis, Erica A. K., et al.
Publicado: (2022)